Somaxon Pharmaceuticals Inc (NASDAQ:SOMX.DL)

CAPS Rating: No stars

A pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.

Recs

0
Player Avatar JorgeAura (23.02) Submitted: 12/6/2012 7:49:17 PM : Underperform Start Price: $1.51 SOMX.DL Score: -90.28

They need more cash in a future.

Featured Broker Partners


Advertisement